
MPR Weekly Dose Podcast Episode 24
Today we talk about the ban on certain electrical stimulation devices, the latest COVID-19 news, a first generic of Daraprim, a New Drug Application for a potential microneedle migraine treatment patc...
5 Mars 20205min

MPR Weekly Dose Podcast Episode 23
This week on the pod we cover a first-in-class cholesterol lowering therapy; a new indication for Trulicity; Macrolide prescriptions in the first trimester and their relation to fetal malformations; a...
27 Feb 20206min

MPR Weekly Dose Podcast Episode 22
This week on the pod we cover the withdrawal of Belviq, the weight-loss drug, from the market; the over-the-counter approval of diclofenac gel and olopatadine eye drops; a new contraceptive transderma...
20 Feb 20206min

MPR Weekly Dose Podcast Episode 21
This week on the pod we cover an insulin pump recall; Pharmacies running out of supplies in light of Covid-19 fears; Investigational Alzheimer disease treatments not meeting trial end points; A new ca...
13 Feb 20205min

MPR Weekly Dose Podcast Episode 20
This week on the Pod we cover the approval of the first oral therapy for peanut allergy; The 2020 immunization schedule; The latest on the coronavirus, including the CDC's shipment of test kits; The w...
6 Feb 20206min

MPR Weekly Dose Podcast Episode 19
This week we discuss the latest news surrounding the novel coronavirus, including the WHO's decision to declare the virus a global emergency; A new triple combo therapy in type 2 diabetes; Updated Tda...
30 Jan 20206min

MPR Weekly Dose Podcast Episode 18
This week we cover the CDC coronavirus health advisory; A possible oral influenza vaccine; A new treatment to reduce the risk of MACE; An FDA Committee vote; And the first approved treatment for thyro...
24 Jan 20205min

MPR Weekly Dose Podcast Episode 17
This week we cover the approval of a cocaine nasal solution; 23andMe's entry into the drug development; The recall of an epilepsy and bipolar treatment; A new nasal spray for seizure patients; And the...
16 Jan 20205min






















